vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and WINMARK CORP (WINA). Click either name above to swap in a different company.

WINMARK CORP is the larger business by last-quarter revenue ($21.1M vs $14.7M, roughly 1.4× IRIDEX CORP). On growth, WINMARK CORP posted the faster year-over-year revenue change (7.9% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 2.4%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Winmark Corporation is an American franchisor of five retail businesses that specialize in buying and selling used goods. The company is based in Minneapolis, Minnesota. Winmark was founded in 1988 as Play It Again Sports Franchise Corporation by Ron Olson and Jeffrey Dahlberg after they purchased the Play It Again Sports franchise rights from Martha Morris. They renamed the company to Grow Biz International Inc. in June 1993. Grow Biz went public in August 1993. In 2000, John Morgan replaced...

IRIX vs WINA — Head-to-Head

Bigger by revenue
WINA
WINA
1.4× larger
WINA
$21.1M
$14.7M
IRIX
Growing faster (revenue YoY)
WINA
WINA
+77.6% gap
WINA
7.9%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
2.4%
WINA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
WINA
WINA
Revenue
$14.7M
$21.1M
Net Profit
$10.0M
Gross Margin
37.2%
Operating Margin
61.7%
Net Margin
47.2%
Revenue YoY
-69.7%
7.9%
Net Profit YoY
3.9%
EPS (diluted)
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
WINA
WINA
Q4 25
$14.7M
$21.1M
Q3 25
$12.5M
$22.6M
Q2 25
$13.6M
$20.4M
Q1 25
$11.9M
$21.9M
Q4 24
$12.7M
$19.5M
Q3 24
$11.6M
$21.5M
Q2 24
$12.6M
$20.1M
Q1 24
$11.8M
$20.1M
Net Profit
IRIX
IRIX
WINA
WINA
Q4 25
$10.0M
Q3 25
$-1.6M
$11.1M
Q2 25
$-994.0K
$10.6M
Q1 25
$-1.7M
$10.0M
Q4 24
$-834.0K
$9.6M
Q3 24
$-1.9M
$11.1M
Q2 24
$-2.7M
$10.4M
Q1 24
$-3.5M
$8.8M
Gross Margin
IRIX
IRIX
WINA
WINA
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
WINA
WINA
Q4 25
61.7%
Q3 25
-11.3%
65.9%
Q2 25
-6.9%
64.0%
Q1 25
-1.7%
62.0%
Q4 24
-3.9%
65.3%
Q3 24
-16.1%
69.4%
Q2 24
-20.9%
64.7%
Q1 24
-28.0%
60.8%
Net Margin
IRIX
IRIX
WINA
WINA
Q4 25
47.2%
Q3 25
-12.6%
49.2%
Q2 25
-7.3%
51.9%
Q1 25
-14.2%
45.4%
Q4 24
-6.6%
49.0%
Q3 24
-16.7%
51.7%
Q2 24
-21.2%
51.8%
Q1 24
-29.5%
43.9%
EPS (diluted)
IRIX
IRIX
WINA
WINA
Q4 25
$2.68
Q3 25
$-0.09
$3.02
Q2 25
$-0.06
$2.89
Q1 25
$-0.10
$2.71
Q4 24
$-0.05
$2.60
Q3 24
$-0.12
$3.03
Q2 24
$-0.16
$2.85
Q1 24
$-0.21
$2.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
WINA
WINA
Cash + ST InvestmentsLiquidity on hand
$6.0M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-53.7M
Total Assets
$29.2M
$24.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
WINA
WINA
Q4 25
$6.0M
$10.3M
Q3 25
$5.6M
$39.7M
Q2 25
$6.8M
$28.8M
Q1 25
$7.2M
$21.8M
Q4 24
$2.4M
$12.2M
Q3 24
$3.9M
$37.2M
Q2 24
$4.1M
$29.4M
Q1 24
$5.4M
$22.9M
Total Debt
IRIX
IRIX
WINA
WINA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
WINA
WINA
Q4 25
$-53.7M
Q3 25
$4.7M
$-26.3M
Q2 25
$6.1M
$-36.8M
Q1 25
$852.0K
$-45.9M
Q4 24
$2.1M
$-51.0M
Q3 24
$2.6M
$-33.7M
Q2 24
$4.2M
$-42.2M
Q1 24
$6.5M
$-52.6M
Total Assets
IRIX
IRIX
WINA
WINA
Q4 25
$29.2M
$24.9M
Q3 25
$28.4M
$53.7M
Q2 25
$31.6M
$43.2M
Q1 25
$34.2M
$37.1M
Q4 24
$29.1M
$26.8M
Q3 24
$30.2M
$52.0M
Q2 24
$31.2M
$44.7M
Q1 24
$34.1M
$38.3M
Debt / Equity
IRIX
IRIX
WINA
WINA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
WINA
WINA
Operating Cash FlowLast quarter
$8.5M
Free Cash FlowOCF − Capex
$8.5M
FCF MarginFCF / Revenue
40.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters
$44.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
WINA
WINA
Q4 25
$8.5M
Q3 25
$-1.2M
$12.3M
Q2 25
$-397.0K
$9.0M
Q1 25
$-1.1M
$15.1M
Q4 24
$-1.2M
$8.5M
Q3 24
$-3.1M
$12.1M
Q2 24
$-1.3M
$8.2M
Q1 24
$-1.6M
$13.4M
Free Cash Flow
IRIX
IRIX
WINA
WINA
Q4 25
$8.5M
Q3 25
$-1.2M
$12.2M
Q2 25
$-410.0K
$9.0M
Q1 25
$-1.2M
$15.0M
Q4 24
$-1.2M
Q3 24
$-3.1M
$12.1M
Q2 24
$8.1M
Q1 24
$-1.7M
$13.3M
FCF Margin
IRIX
IRIX
WINA
WINA
Q4 25
40.3%
Q3 25
-9.4%
53.8%
Q2 25
-3.0%
44.0%
Q1 25
-9.8%
68.6%
Q4 24
-9.8%
Q3 24
-26.5%
56.3%
Q2 24
40.4%
Q1 24
-14.0%
66.0%
Capex Intensity
IRIX
IRIX
WINA
WINA
Q4 25
0.1%
Q3 25
0.1%
0.3%
Q2 25
0.1%
0.3%
Q1 25
0.1%
0.2%
Q4 24
0.1%
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.5%
Q1 24
0.0%
0.4%
Cash Conversion
IRIX
IRIX
WINA
WINA
Q4 25
0.86×
Q3 25
1.10×
Q2 25
0.85×
Q1 25
1.51×
Q4 24
0.88×
Q3 24
1.09×
Q2 24
0.79×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons